Invested in
Viatris?
Attention Viatris shareholders: contact investor lawyers for a free evaluation of your potential claims for compensation today.
- Did you acquire shares of Viatris, Inc. (NASDAQ: VTRS) before March 1, 2021, and do you still hold your Viatris shares?
- Are you concerned about the recent performance of Viatris’s stock price?
- Are you concerned about the conduct of Viatris’s officers and directors related to Viatris Inc.’s allegedly deficient financial reporting?
- Would you like your potential options for compensation and/or redress to be reviewed by an experienced team of investor lawyers?
Request a free case evaluation of your potential claims for compensation today, via email at arosca@rscounsel.law, through the contact form on this page, or by calling 888-998-0530.
Contact Us About Your
Investments
Free Case Evaluation
The Viatris Class Action Investigation page is the resource for long-term shareholders of Viatris who would like to evaluate potential compensation claims.
- Free Case Evaluation
- No Fees if No Recovery
- Contact Us Today
We can also do a Zoom call to discuss your matter.
Posted September 29, 2023
Viatris Class Action Investigation
Securities attorneys Alan Rosca, Paul Scarlato, and Kathryn Weidner have been investigating potential securities violations and corporate misconduct, as well as questionable business practices involving Viatris, Inc. and have identified potential areas of concern for Viatris investors.
What Viatris Investors May Do
VTRS investors interested in an evaluation of their potential options to seek compensation and/or pursue claims related to their Viatris investment may contact investor rights attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner. Claims that are not timely pursued may expire or otherwise be lost, generally speaking.
Get in Touch with an Experienced Team of Investor Attorneys
Attorneys Rosca, Scarlato, and Weidner have extensive experience in seeking compensation related to investor harm and pursuing claims arising out of alleged violations of securities law and/or corporate misconduct, and are currently evaluating potential claims on behalf of investors in Viatris, Inc.
They typically work on a contingent fee basis, do not require any money down from their clients, advance case expenses, and only get paid for their fees and expenses if and when successful, following review and approval by the Court of any fee application.
Concerned VTRS stock investors may contact attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner to discuss their potential options toll free at 888-998-0530, via email at arosca@rscounsel.law, or through the contact form on this webpage.
Potential Compensation Claims
Has Viatris Been Accused of Misconduct?
Viatris, Inc. (“Viatris”) and its executives have been the subject of two class action lawsuits, filed in the United States District Court for the Western District of Pennsylvania in mid-2023.
Viatris and certain of its executives are accused in class action lawsuits of, among others, violating securities laws by allegedly making materially false and/or misleading statements and failing to disclose materially adverse facts that allegedly caused Viatris’ stock to trade at artificially inflated prices. According to the complaints, Viatris and those executives allegedly misrepresented company’s performance while repeatedly assuring investors of the effectiveness of Viatris’ strategic plans.
The complaints alleged that contrary to representations made to investors, Viatris was struggling with increased competition in its complex generics business. As a result, the company allegedly failed to effectively manage its base business erosion and prevent declining revenues.
What Happened to Viatris’ Stock Price?
On February 28, 2022, Viatris filed its Form 8-K announcing, among others, that it decided to sell its biosimilar business, previously represented as being a core part of the Company’s long-term investment strategy, according to the complaint.
Furthermore, Viatris reported lower-than expected guidance for 2022. Following the publication of the 8-K, VTRS stock price allegedly declined approximatively 24% to close at a little over $11 per share. Data from Google Finance indicates that as of the date of this post the value of Viatris shares declined more than 38% since it became publicly traded.
Do Viatris Shareholders Have Claims for Compensation?
Investor rights attorneys Alan Rosca, Paul Scarlato, and Kathryn Weidner at Rosca Scarlato are investigating potential options and evaluating potential claims for compensation and/or other redress on behalf of Viatris’s long-term shareholders whose share value dropped following the alleged misrepresentations and omissions regarding Viatris’s financial reporting and failure to disclose material information regarding the base business. The Rosca Scarlato attorneys have decades of combined experience representing victims of corporate or financial misconduct.
If you are a Viatris investor who has acquired VTRS shares before March 2021 and are concerned about the drop in the value of your investment, you may contact attorneys Alan Rosca, Paul Scarlato, or Kathryn Weidner to learn more about your rights and for an evaluation of your potential claims, or to provide useful information.
All consultations are free. The Rosca Scarlato attorneys typically take cases like this on a contingency fee basis, advance all case costs, and only get paid for their fees and expenses if and when they are successful, following review and approval by the Court of any fee application.
To reach attorney Alan Rosca or his colleagues, Viatris investors may call 888-998-0530, email arosca@rscounsel.law, or leave a message through the contact form on this webpage.
The general considerations on this page are for informational purposes only and do not constitute legal advice. Such legal advice can only be offered once the attorneys discuss each investor’s situation, learn of the relevant facts and can tailor any advice to that investor’s facts. The Viatris Class Action Investigation page is not affiliated with Viatris, Inc. There has not been an adjudication on the merits of any allegations referenced in this blog post, as of the date of the posting.
Contact info:
Rosca Scarlato LLC – 216-946-7070 / 888-998-0530.
Alan Rosca – arosca@rscounsel.law
Paul Scarlato – pscarlato@rscounsel.law
Kathryn Weidner – kweidner@rscounsel.law
Recent Investigations
DISCLAIMER
In our legal system, every person is innocent until and unless found guilty by a court of law or a tribunal. Whenever we reference “allegations” or charges that are “alleged,” such allegations or charges have not been proven, and are merely accusations, not findings of fault, as of the date of the blog. We do not have, nor do we undertake, a duty to continue to monitor or follow matters about which we report, and/or to publish subsequent updates regarding various developments that may occur in such matters. Readers are encouraged to conduct their own research regarding any such matters and any developments that may or may not have occurred in such matters. Also, the Brokercheck report linked to some of our blogs is the up-to-date version as of the date of accessing by the reader. The information in our blogs is current as of the date of the drafting of the blog, and given that sometimes certain past complaints may no longer be listed in newer Brokercheck reports, some of the events referenced in some of our blogs may later on be removed from newer Brokercheck reports. Visitors may check the most recent version of each brokercheck report at www.finra.org, and may contact FINRA for the earlier version of the Brokercheck report upon which various blogs may be based.
